ENDONOVO THERAPEUTICS, INC. Quarterly Common Stock, Shares Authorized from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Endonovo Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q3 2023.
  • Endonovo Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2023 was 2.5B shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 2.5B 0 0% Sep 30, 2023 10-Q/A 2023-12-29
Q2 2023 2.5B 0 0% Jun 30, 2023 10-Q 2023-08-21
Q1 2023 2.5B 0 0% Mar 31, 2023 10-Q 2023-05-22
Q4 2022 2.5B 0 0% Dec 31, 2022 10-Q/A 2023-12-29
Q3 2022 2.5B 0 0% Sep 30, 2022 10-Q 2022-11-21
Q2 2022 2.5B 0 0% Jun 30, 2022 10-Q 2022-08-22
Q1 2022 2.5B 0 0% Mar 31, 2022 10-Q 2022-05-19
Q4 2021 2.5B 0 0% Dec 31, 2021 10-K 2023-04-17
Q3 2021 2.5B 0 0% Sep 30, 2021 10-Q 2021-11-19
Q2 2021 2.5B 0 0% Jun 30, 2021 10-Q 2021-08-23
Q1 2021 2.5B 0 0% Mar 31, 2021 10-Q 2021-05-24
Q4 2020 2.5B 0 0% Dec 31, 2020 10-K 2022-04-14
Q3 2020 2.5B 0 0% Sep 30, 2020 10-Q 2020-11-19
Q2 2020 2.5B 0 0% Jun 30, 2020 10-Q 2020-08-19
Q1 2020 2.5B 0 0% Mar 31, 2020 10-Q 2020-06-12
Q4 2019 2.5B 0 0% Dec 31, 2019 10-K 2021-04-13
Q3 2019 2.5B 0 0% Sep 30, 2019 10-Q 2019-11-19
Q2 2019 2.5B +2B +400% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 2.5B +2B +400% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 2.5B 0 0% Dec 31, 2018 10-K 2020-05-04
Q3 2018 2.5B +2B +400% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 500M 0 0% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 500M 0 0% Mar 31, 2018 10-Q 2018-05-18
Q4 2017 2.5B +2B +400% Dec 31, 2017 10-K 2019-04-15
Q3 2017 500M +250M +100% Sep 30, 2017 10-Q/A 2017-11-09
Q2 2017 500M +250M +100% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 500M +250M +100% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 500M +250M +100% Dec 31, 2016 10-K 2018-04-06
Q3 2016 250M 0 0% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 250M 0 0% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 250M 0 0% Mar 31, 2016 10-Q/A 2016-05-27
Q4 2015 250M 0 0% Dec 31, 2015 10-K 2017-04-17
Q3 2015 250M Sep 30, 2015 10-Q 2015-11-23
Q2 2015 250M Jun 30, 2015 10-Q 2015-08-19
Q1 2015 250M Mar 31, 2015 10-Q/A 2015-06-15
Q4 2014 250M Dec 31, 2014 10-K/A 2016-05-17
Q3 2013 250M +175M +233% Sep 30, 2013 10-Q 2013-12-18
Q2 2013 75M 0 0% Jun 30, 2013 10-Q/A 2013-08-28
Q1 2013 75M 0 0% Mar 31, 2013 10-Q/A 2013-06-21
Q4 2012 250M +175M +233% Dec 31, 2012 10-Q 2013-12-18
Q3 2012 75M Sep 30, 2012 10-Q 2012-11-29
Q2 2012 75M Jun 30, 2012 10-Q 2012-08-20
Q1 2012 75M Mar 31, 2012 10-Q 2012-05-21
Q4 2011 75M 0 0% Dec 31, 2011 10-K/A 2013-05-03
Q4 2010 75M Dec 31, 2010 10-K 2012-04-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.